vs
WD 40 CO（WDFC）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
WD 40 CO的季度营收约是再鼎医药的1.2倍（$154.4M vs $127.1M），再鼎医药同比增速更快（17.1% vs 0.6%），WD 40 CO自由现金流更多（$9.1M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 5.4%）
WD-40公司是全球知名的消费及工业维护用品生产商，核心产品为同名多功能防锈润滑剂，同时布局清洁剂、除油剂、特殊润滑产品等品类，业务覆盖全球170余个国家和地区，服务零售、工业、汽车后市场等多个领域。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
WDFC vs ZLAB — 直观对比
营收规模更大
WDFC
是对方的1.2倍
$127.1M
营收增速更快
ZLAB
高出16.5%
0.6%
自由现金流更多
WDFC
多$35.7M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
5.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $154.4M | $127.1M |
| 净利润 | $17.5M | — |
| 毛利率 | 56.2% | 51.0% |
| 营业利润率 | 15.1% | -54.6% |
| 净利率 | 11.3% | — |
| 营收同比 | 0.6% | 17.1% |
| 净利润同比 | -7.8% | — |
| 每股收益（稀释后） | $1.28 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收WDFCZLAB
| Q4 25 | $154.4M | $127.1M | ||
| Q3 25 | $163.5M | $115.4M | ||
| Q2 25 | $156.9M | $109.1M | ||
| Q1 25 | $146.1M | $105.7M | ||
| Q4 24 | $153.5M | $108.5M | ||
| Q3 24 | $156.0M | $101.8M | ||
| Q2 24 | $155.0M | $100.1M | ||
| Q1 24 | $139.1M | $87.1M |
净利润WDFCZLAB
| Q4 25 | $17.5M | — | ||
| Q3 25 | $21.2M | $-36.0M | ||
| Q2 25 | $21.0M | $-40.7M | ||
| Q1 25 | $29.9M | $-48.4M | ||
| Q4 24 | $18.9M | — | ||
| Q3 24 | $16.8M | $-41.7M | ||
| Q2 24 | $19.8M | $-80.3M | ||
| Q1 24 | $15.5M | $-53.5M |
毛利率WDFCZLAB
| Q4 25 | 56.2% | 51.0% | ||
| Q3 25 | 54.7% | 59.5% | ||
| Q2 25 | 56.2% | 60.6% | ||
| Q1 25 | 54.6% | 63.6% | ||
| Q4 24 | 54.8% | 61.5% | ||
| Q3 24 | 54.1% | 64.1% | ||
| Q2 24 | 53.1% | 64.9% | ||
| Q1 24 | 52.4% | 61.4% |
营业利润率WDFCZLAB
| Q4 25 | 15.1% | -54.6% | ||
| Q3 25 | 17.1% | -42.3% | ||
| Q2 25 | 17.4% | -50.3% | ||
| Q1 25 | 15.9% | -53.3% | ||
| Q4 24 | 16.4% | -62.6% | ||
| Q3 24 | 15.4% | -66.6% | ||
| Q2 24 | 17.5% | -76.0% | ||
| Q1 24 | 15.1% | -80.7% |
净利率WDFCZLAB
| Q4 25 | 11.3% | — | ||
| Q3 25 | 13.0% | -31.2% | ||
| Q2 25 | 13.4% | -37.3% | ||
| Q1 25 | 20.4% | -45.8% | ||
| Q4 24 | 12.3% | — | ||
| Q3 24 | 10.8% | -40.9% | ||
| Q2 24 | 12.8% | -80.2% | ||
| Q1 24 | 11.2% | -61.4% |
每股收益（稀释后）WDFCZLAB
| Q4 25 | $1.28 | $-0.05 | ||
| Q3 25 | $1.57 | $-0.03 | ||
| Q2 25 | $1.54 | $-0.04 | ||
| Q1 25 | $2.19 | $-0.04 | ||
| Q4 24 | $1.39 | $-0.09 | ||
| Q3 24 | $1.23 | $-0.04 | ||
| Q2 24 | $1.46 | $-0.08 | ||
| Q1 24 | $1.14 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $48.6M | $689.6M |
| 总债务越低越好 | $85.7M | — |
| 股东权益账面价值 | $264.1M | $715.5M |
| 总资产 | $459.7M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.32× | — |
8季度趋势，按日历期对齐
现金及短期投资WDFCZLAB
| Q4 25 | $48.6M | $689.6M | ||
| Q3 25 | $58.1M | $717.2M | ||
| Q2 25 | $51.7M | $732.2M | ||
| Q1 25 | $53.0M | $757.3M | ||
| Q4 24 | $54.9M | $779.7M | ||
| Q3 24 | $46.7M | $616.1M | ||
| Q2 24 | $45.3M | $630.0M | ||
| Q1 24 | $55.4M | $650.8M |
总债务WDFCZLAB
| Q4 25 | $85.7M | — | ||
| Q3 25 | $86.2M | — | ||
| Q2 25 | $85.6M | — | ||
| Q1 25 | $84.4M | — | ||
| Q4 24 | $84.6M | — | ||
| Q3 24 | $86.0M | — | ||
| Q2 24 | $85.5M | — | ||
| Q1 24 | $85.9M | — |
股东权益WDFCZLAB
| Q4 25 | $264.1M | $715.5M | ||
| Q3 25 | $268.2M | $759.9M | ||
| Q2 25 | $257.1M | $791.7M | ||
| Q1 25 | $242.1M | $810.8M | ||
| Q4 24 | $226.3M | $840.9M | ||
| Q3 24 | $230.5M | $667.7M | ||
| Q2 24 | $222.2M | $704.2M | ||
| Q1 24 | $216.3M | $762.2M |
总资产WDFCZLAB
| Q4 25 | $459.7M | $1.2B | ||
| Q3 25 | $475.8M | $1.2B | ||
| Q2 25 | $456.0M | $1.2B | ||
| Q1 25 | $458.3M | $1.2B | ||
| Q4 24 | $447.3M | $1.2B | ||
| Q3 24 | $449.0M | $985.3M | ||
| Q2 24 | $443.6M | $987.4M | ||
| Q1 24 | $442.0M | $988.4M |
负债/权益比WDFCZLAB
| Q4 25 | 0.32× | — | ||
| Q3 25 | 0.32× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.35× | — | ||
| Q4 24 | 0.37× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.38× | — | ||
| Q1 24 | 0.40× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $10.0M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $9.1M | $-26.7M |
| 自由现金流率自由现金流/营收 | 5.9% | -21.0% |
| 资本支出强度资本支出/营收 | 0.6% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.57× | — |
| 过去12个月自由现金流最近4个季度 | $78.2M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流WDFCZLAB
| Q4 25 | $10.0M | $-26.0M | ||
| Q3 25 | $29.9M | $-32.0M | ||
| Q2 25 | $35.1M | $-31.0M | ||
| Q1 25 | $8.0M | $-61.7M | ||
| Q4 24 | $14.9M | $-55.8M | ||
| Q3 24 | $27.2M | $-26.8M | ||
| Q2 24 | $19.9M | $-42.2M | ||
| Q1 24 | $18.0M | $-90.1M |
自由现金流WDFCZLAB
| Q4 25 | $9.1M | $-26.7M | ||
| Q3 25 | $28.6M | $-35.0M | ||
| Q2 25 | $34.0M | $-33.9M | ||
| Q1 25 | $6.6M | $-63.2M | ||
| Q4 24 | $14.2M | $-58.4M | ||
| Q3 24 | $26.4M | $-28.2M | ||
| Q2 24 | $18.7M | $-42.9M | ||
| Q1 24 | $16.7M | $-91.1M |
自由现金流率WDFCZLAB
| Q4 25 | 5.9% | -21.0% | ||
| Q3 25 | 17.5% | -30.4% | ||
| Q2 25 | 21.6% | -31.1% | ||
| Q1 25 | 4.5% | -59.9% | ||
| Q4 24 | 9.3% | -53.8% | ||
| Q3 24 | 16.9% | -27.7% | ||
| Q2 24 | 12.0% | -42.9% | ||
| Q1 24 | 12.0% | -104.5% |
资本支出强度WDFCZLAB
| Q4 25 | 0.6% | 0.5% | ||
| Q3 25 | 0.8% | 2.6% | ||
| Q2 25 | 0.7% | 2.6% | ||
| Q1 25 | 0.9% | 1.5% | ||
| Q4 24 | 0.5% | 2.4% | ||
| Q3 24 | 0.5% | 1.3% | ||
| Q2 24 | 0.8% | 0.7% | ||
| Q1 24 | 0.9% | 1.1% |
现金转化率WDFCZLAB
| Q4 25 | 0.57× | — | ||
| Q3 25 | 1.41× | — | ||
| Q2 25 | 1.67× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.79× | — | ||
| Q3 24 | 1.62× | — | ||
| Q2 24 | 1.00× | — | ||
| Q1 24 | 1.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
WDFC
| Other | $82.6M | 53% |
| WD40Multi Use Product | $56.0M | 36% |
| WD40Specialist | $9.0M | 6% |
| Other Maintenance Products | $4.0M | 3% |
| Homecare And Cleaning Products | $2.7M | 2% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
